AAAAAA
Results: 1-25/104
Authors:
COOREMAN MP
SENTJENS R
WEEGINK C
CUYPERS T
REESINK HW
Citation: Mp. Cooreman et al., EFFICACY OF 2-WEEK 3-TIMES-DAILY HIGH-DOSE INTERFERON-ALPHA TREATMENTFOR CHRONIC HEPATITIS-C VIRUS-DISEASE, Hepatology, 28(4), 1998, pp. 486-486
Authors:
DAMEN M
WEEGINK CJ
MAUSERBUNSCHOTEN EP
CUYPERS HTM
VANDERBERG HM
CHAMULEAU RAFM
REESINK HW
Citation: M. Damen et al., VIROLOGICAL RESPONSE IN CHRONIC HCV PATIENTS DURING A 3-YEARS IFN TREATMENT COURSE, COMPARED WITH A 6-MONTH TREATMENT COURSE AND NO TREATMENT, Hepatology, 28(4), 1998, pp. 1383-1383
STABILITY OF HEPATITIS-C VIRUS-RNA DURING SPECIMEN HANDLING AND STORAGE PRIOR TO NASBA AMPLIFICATION
Authors:
DAMEN M
SILLEKENS P
SJERPS M
MELSERT R
FRANTZEN I
REESINK HW
LELIE PN
CUYPERS HTM
Citation: M. Damen et al., STABILITY OF HEPATITIS-C VIRUS-RNA DURING SPECIMEN HANDLING AND STORAGE PRIOR TO NASBA AMPLIFICATION, Journal of virological methods, 72(2), 1998, pp. 175-184
Authors:
TERBORG F
TENKATE FJW
CUYPERS HTM
LEENTVAARKUIJPERS A
OOSTING J
WERTHEIMVANDILLEN PME
HONKOOP P
RASCH MC
DEMAN RA
VANHATTUM J
CHAMULEAU RAFM
REESINK HW
JONES EA
Citation: F. Terborg et al., RELATION BETWEEN LABORATORY TEST-RESULTS AND HISTOLOGICAL HEPATITIS ACTIVITY IN INDIVIDUALS POSITIVE FOR HEPATITIS-B SURFACE-ANTIGEN AND ANTIBODIES TO HEPATITIS-B E-ANTIGEN, Lancet, 351(9120), 1998, pp. 1914-1918
Authors:
ENGELFRIET CP
REESINK HW
Citation: Cp. Engelfriet et Hw. Reesink, USE OF CORD BLOOD PROGENITOR CELLS AS AN ALTERNATIVE FOR BONE-MARROW TRANSPLANTATION, Vox sanguinis, 75(2), 1998, pp. 156-172
Authors:
ENGELFRIET CP
REESINK HW
Citation: Cp. Engelfriet et Hw. Reesink, THE USE AND QUALITY-CONTROL OF LEUKOCYTE-DEPLETED CELL CONCENTRATES, Vox sanguinis, 75(1), 1998, pp. 82-83
Authors:
REESINK HW
ENGELFRIET CP
VRIELINK H
KRUSIUS T
LANKINEN M
FLANAGAN P
BARBARA J
GILL P
DODD RY
BUSCH MP
PRATI D
MOZZI F
SIRCHIA G
DIEKAMP U
EPSTEIN JS
TABOR E
MARTINVEGA C
HERNANDEZ JM
Citation: Hw. Reesink et al., CONSEQUENCES OF NUCLEIC-ACID AMPLIFICATION TESTING FOR BLOOD-TRANSFUSION CENTERS, Vox sanguinis, 74(4), 1998, pp. 263-270
Authors:
VANDENBURG PJM
VRIELINK H
REESINK HW
Citation: Pjm. Vandenburg et al., DONOR SELECTION - THE EXCLUSION OF HIGH-RISK DONORS, Vox sanguinis, 74, 1998, pp. 499-502
Authors:
VANDERMEER PF
REBERS SPH
PIETERSZ RNI
REESINK HW
Citation: Pf. Vandermeer et al., COMPODOCK(R), A NEW DEVICE FOR STERILE DOCKING, Transfusion, 38(10), 1998, pp. 34-34
Authors:
VANDERMEER PF
REBERS SPH
PIETERSZ RNI
REESINK HW
Citation: Pf. Vandermeer et al., COMPARISON OF 3 LEUKO-REDUCING FILTERS FOR RED-CELL CONCENTRATES, USED AT 4-DEGREES-C AND AT 20-DEGREES-C, Transfusion, 38(10), 1998, pp. 35-35
Authors:
VANDERMEER PF
VANZANTEN AP
PIETERSZ RNI
REESINK HW
Citation: Pf. Vandermeer et al., VARIATION IN PH MEASUREMENT OF PLATELETS, STORED IN ADDITIVE SOLUTION, BY 2 BLOOD-GAS ANALYZERS, Transfusion, 38(10), 1998, pp. 40-40
Authors:
VANDERMEER PF
REBERS SPH
PIETERSZ RNI
HINLOOPEN B
DEKKER WJA
REESINK HW
Citation: Pf. Vandermeer et al., STORAGE OF PLATELET CONCENTRATES IN PLASMA OR IN A PLATELET ADDITIVE SOLUTION, Transfusion, 38(10), 1998, pp. 51-51
Authors:
VANDENBURG PJM
REESINK HW
Citation: Pjm. Vandenburg et Hw. Reesink, SEXUAL RISK-FACTORS OF BLOOD-DONORS WITH POSITIVE AND NEGATIVE CONFIRMATORY TEST-RESULTS - A MULTIVARIATE-ANALYSIS, Transfusion, 38(10), 1998, pp. 66-66
Authors:
VANDENBURG PJM
REESINK HW
Citation: Pjm. Vandenburg et Hw. Reesink, PARENTERAL RISK-FACTORS OF BLOOD-DONORS WITH POSITIVE AND NEGATIVE CONFIRMATORY TEST-RESULTS - A MULTIVARIATE-ANALYSIS, Transfusion, 38(10), 1998, pp. 67-67
Authors:
VANDENBURG PJM
HOFFVANRUTH R
REESINK HW
Citation: Pjm. Vandenburg et al., INTRODUCTION OF A DONOR QUESTIONNAIRE FOR THE PREVENTION OF WINDOW INFECTIONS, Transfusion, 38(10), 1998, pp. 71-71
Authors:
VRIELINK H
VANDERMEER CBM
REESINK HW
Citation: H. Vrielink et al., EVALUATION OF 4 ANTI-HTLV-I AND ANTI-HTLV-II ASSAYS, Transfusion, 38(10), 1998, pp. 189-189
Authors:
VANDENBURG PJM
VRIELINK H
REESINK HW
Citation: Pjm. Vandenburg et al., TIME-INTERVAL OF 5 YEARS BETWEEN HTLV-I INFECTION AND THE APPEARANCE OF ANTIBODIES IN A REPEAT BLOOD-DONOR, Transfusion, 38(10), 1998, pp. 191-191
Authors:
VRIELINK H
HABIBUW MR
SCHULLER M
REESINK HW
Citation: H. Vrielink et al., SENSITIVITY AND SPECIFICITY OF 2 ANTI-HIV-1 2 ELISAS/, Transfusion, 38(10), 1998, pp. 199-199
Authors:
VRIELINK H
HABIBUW MR
SCHULLER M
REESINK HW
Citation: H. Vrielink et al., SENSITIVITY AND SPECIFICITY OF 2 ANTI-HIV-1 2(O) ELISAS OF MUREX/, Transfusion, 38(10), 1998, pp. 203-203
Authors:
VRIELINK H
HABIBUW MR
SCHULLER M
REESINK HW
Citation: H. Vrielink et al., RELATIVE SENSITIVITY OF 3 ANTI-HIV-1 2 ELISAS FROM MUREX AND ORTHO/, Transfusion, 38(10), 1998, pp. 204-204
Authors:
HABIBUW MR
VRIELINK H
REESINK HW
BELD M
Citation: Mr. Habibuw et al., EVALUATION OF NUCLEIC-ACID AMPLIFICATION TECHNOLOGY (NAT) EFFICIENCY OF HEPATITIS-C VIRUS (HCV) IN POOL SCREENING SYSTEMS, Transfusion, 38(10), 1998, pp. 206-206
Authors:
VRIELINK H
HABIBUW MR
SCHULLER M
REESINK HW
Citation: H. Vrielink et al., EVALUATION OF A NEW HBSAG ELISA, Transfusion, 38(10), 1998, pp. 220-220
Authors:
VRIELINK H
REESINK HW
PETERSON JE
KOCHESKY R
LEE S
Citation: H. Vrielink et al., PEPTIDE ANALYSIS IN NS5 ONLY RIBA INDETERMINATE SERA, Transfusion, 38(10), 1998, pp. 347-347
Authors:
VRIELINK H
ZAAIJER HL
REESINK HW
Citation: H. Vrielink et al., THE CLINICAL RELEVANCE OF HTLV TYPE-I AND TYPE-II IN TRANSFUSION MEDICINE, Transfusion medicine reviews, 11(3), 1997, pp. 173-179
Authors:
ENGELFRIET CP
REESINK HW
Citation: Cp. Engelfriet et Hw. Reesink, MANAGEMENT OF ALLOIMMUNIZED, REFRACTOR PATIENTS IN NEED OF PLATELET TRANSFUSIONS, Vox sanguinis, 73(3), 1997, pp. 191-192